New Type of Cancer Immunotherapeutic Approved by FDA: What It Means for Leukemia Patients

FDA approved image

Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment of certain patients with acute lymphoblastic leukemia (ALL).

Read More

SABCS 2014: Immunotherapy Shows Early Promise for Triple-negative Breast Cancer Patients

Print

After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope for women with a very challenging form of breast cancer—triple-negative breast …

Read More